-
November 4, 2021 Why We’re Excited About Compass Pathways’ New Clinical Trial Treating PTSD with PsilocybinCompass Pathways (Nasdaq: CMPS) has announced the launch of a brand new psychedelic clinical trial,...
-
October 13, 2021 Why Psychedelic Stocks Have Crashed in the Last 3 MonthsOur resident psychedelic investor explains why psychedelic stocks are plummeting, and why patience can pay...